Handok strengthens partnership with Alexion through renewal and new agreements
On the 17th, Handok(Chairman Young-Jin Kim) and U.S. Alexion Pharmaceuticals(CEO David L. Hallal) renewed the agreement of Soliris and signed a Korean sales agreement of rare disease therapies, ‘Strensiq’ and ‘Kanuma,’ to strengthen their strategic partnership.
Handok started the partnership wit...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
